Cargando…
Metformin for cancer and aging prevention: is it a time to make the long story short?
During the last decade, the burst of interest is observed to antidiabetic biguanide metformin as candidate drug for cancer chemoprevention. The analysis of the available data have shown that the efficacy of cancer preventive effect of metformin (MF) and another biguanides, buformin (BF) and phenform...
Autor principal: | Anisimov, Vladimir N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741834/ https://www.ncbi.nlm.nih.gov/pubmed/26583576 |
Ejemplares similares
-
Metformin for aging and cancer prevention
por: Anisimov, Vladimir N.
Publicado: (2010) -
Aging and cancer: Is glucose a mediator between them?
por: Golubev, Alexey G., et al.
Publicado: (2019) -
Gene therapy enters the pharma market: The short story of a long journey
por: Büning, Hildegard
Publicado: (2013) -
Metformin and rapamycin are master-keys for understanding the relationship between cell senescent, aging and cancer
por: Anisimov, Vladimir N.
Publicado: (2013) -
A long story for a short peptide: therapeutic efficacy of a cleavage-specific tau antibody
por: Amadoro, Giuseppina, et al.
Publicado: (2021)